3 | SEC Filings Hub

Filing metadata

Accession number: 0001493152-22-014954
Form type: Form 3
Filer: Anebulo Pharmaceuticals, Inc.
CIK: CIK 1815974
Filed: May 24, 2022
Reporting period: May 20, 2022
Description: Initial ownership

Documents

0001493152-22-014954-index.htm

Complete submission

0001493152-22-014954.txt

directory listing

Filed by

Anebulo Pharmaceuticals, Inc.